Modulators of chromosome 9 open reading frame 72 gene expression and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 12139517
APP PUB NO 20200339638A1
SERIAL NO

16856774

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure provides compositions and methods for modulating transcription of mutant C9orf72 gene alleles in patients in need thereof, including patients having a C9orf72-related disease such as amyotrophic lateral sclerosis (ALS) or frontotemporal dementia (FTD).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SANGAMO THERAPEUTICS INC501 CANAL BLVD SUITE A100 RICHMOND CA 94804

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Nabhan, Joseph F Arlington, US 6 20
Pattamatta, Amrutha Watertown, US 4 1
Samie, Mohammad Richmond, US 3 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 May 12, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 May 12, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 12, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00